Katherine Clayton's profile

Katherine Clayton

CEO

OmniVis

I'm working on

4 months ago

Redefining Molecular Testing with Cutting-Edge Handheld Devices

About

Revolutionizing pathogen testing, Katherine pioneers handheld devices, reshaping molecular testing with unparalleled efficiency. Redefining molecular testing in a compact, game-changing approach, Katherine and her team developed a handheld device to perform molecular testing in <30 minutes.

Partnering listings

Learn more

OmniVis

Rapid handheld genetic quality assessment device for plant materials using LAMP and particle diffusometry

OmniVis offers a portable, point-of-care diagnostic platform combining Loop-Mediated Isothermal Amplification (LAMP) with proprietary particle diffusometry (PD) readout for rapid in-field genetic quality assessment of pl...

TechnologyIn developmentCompany

Katherine Clayton

CEO

OmniVis

Work experience

OmniVis

CEO

Purdue University

Postdoctoral Scientist

2017 - 2018

Syracuse University

Postdoctoral Scientist